Please log in to view this page
Username
Password
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
